Zhang Lei, Li Honglin, Zhang Jianwei, Kong Xinliang, Wu Zhijuan, Dong Shuangqian, Qin Xiuyun
The First Clinical College, Shandong University of Traditional Chinese Medicine.
Hospital Affiliated to Shandong University of Traditional Chinese Medicine.
Medicine (Baltimore). 2020 Jul 31;99(31):e21538. doi: 10.1097/MD.0000000000021538.
With the increase in the incidence of premature ovarian insufficiency (POI) over the years, the ovarian function has become one of the integral aspects of research in reproductive medicine today. POI seriously affects the physical and mental health of women, especially reproductive health. Studies show both complementary and alternative therapies to be effective in treating POIs. However, consistency in conclusions is still far-fetched. In light of this, we will carry out a study to evaluate the effectiveness and safety of complementary and alternative therapies for POIs. We therefore develop a study protocol for a proposed network meta-analysis (NMA) and systematic review on POI.
The following electronic bibliographic database will be searched: VIP database, Wanfang database, Chinese National Knowledge Infrastructure (CNKI), The Cochrane Library, PubMed, EMBASE and Web of Science from inception till 31 December 2019. A search at the World Health Organization (WHO) International Clinical Trials Registry Platform will also be done. Subsequently, the searched data will undergo independent screening, retrieving, and risk of bias assessment by 2 reviewers. Analysis will be performed on included studies using the NMA technique. Next, the primary outcomes will be compared using ADDIS 1.16.5 and Stata 15.0.
The safety and effectiveness of alternative and complementary therapies used in the treatment of POI will be compared and evaluated.
This work will provide high-quality evidence for clinicians in the field to build on for best practices in effective interventions (complementary and alternative therapies) for POI.
This NMA is a secondary research which based on some previously published data. Therefore, the ethical approval was not necessary.
CRD42020163873.
近年来,随着卵巢早衰(POI)发病率的上升,卵巢功能已成为当今生殖医学研究的重要方面之一。POI严重影响女性的身心健康,尤其是生殖健康。研究表明,补充和替代疗法在治疗POI方面是有效的。然而,结论的一致性仍难以实现。有鉴于此,我们将开展一项研究,以评估补充和替代疗法治疗POI的有效性和安全性。因此,我们制定了一项关于拟议的网络荟萃分析(NMA)和POI系统评价的研究方案。
将检索以下电子文献数据库:维普数据库、万方数据库、中国知网、考克兰图书馆、PubMed、EMBASE和Web of Science,检索时间从建库至2019年12月31日。还将在世界卫生组织(WHO)国际临床试验注册平台上进行检索。随后,由两名评审员对检索到的数据进行独立筛选、提取和偏倚风险评估。将使用NMA技术对纳入的研究进行分析。接下来,将使用ADDIS 1.16.5和Stata 15.0对主要结局进行比较。
将比较和评估用于治疗POI的替代和补充疗法的安全性和有效性。
这项工作将为该领域的临床医生提供高质量的证据,以便在POI的有效干预措施(补充和替代疗法)的最佳实践中加以借鉴。
本NMA是一项基于一些先前发表数据的二次研究。因此,无需伦理批准。
PROSPERO注册号:CRD42020163873。